Whither vaccines?

Charlene M.C. Rodrigues; Marta V. Pinto; Manish Sadarangani; Stanley A. Plotkin

doi:10.1016/S0163-4453(17)30184-6

Whither vaccines?

Charlene M.C. Rodrigues
, Marta V. Pinto
, Manish Sadarangani
, Stanley A. Plotkin

Resultado de pesquisa: ???type-name??? › ???researchoutput.researchoutputtypes.contributiontojournal.article??? › revisão de pares

26 Citações (Scopus)

Resumo

Currently used vaccines have had major effects on eliminating common infections, largely by duplicating the immune responses induced by natural infections. Now vaccinology faces more complex problems, such as waning antibody, immunosenescence, evasion of immunity by the pathogen, deviation of immunity by the microbiome, induction of inhibitory responses, and complexity of the antigens required for protection. Fortunately, vaccine development is now incorporating knowledge from immunology, structural biology, systems biology and synthetic chemistry to meet these challenges. In addition, international organisations are developing new funding and licensing pathways for vaccines aimed at pathogens with epidemic potential that emerge from tropical areas.

Idioma original	???core.languages.en_GB???
Páginas (de-até)	S2-S9
Revista	Journal of Infection
Volume	74
DOIs	https://doi.org/10.1016/S0163-4453(17)30184-6
Estado da publicação	???researchoutput.status.published??? - jun. 2017
Publicado externamente	Sim

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

ODS 3 Boa saúde e bem-estar

Acesso ao documento

10.1016/S0163-4453(17)30184-6

Outros arquivos e links

Link to publication in Scopus

Citar isto

@article{38fd9b3eb62740f2b70503a7bce445ce,

title = "Whither vaccines?",

abstract = "Currently used vaccines have had major effects on eliminating common infections, largely by duplicating the immune responses induced by natural infections. Now vaccinology faces more complex problems, such as waning antibody, immunosenescence, evasion of immunity by the pathogen, deviation of immunity by the microbiome, induction of inhibitory responses, and complexity of the antigens required for protection. Fortunately, vaccine development is now incorporating knowledge from immunology, structural biology, systems biology and synthetic chemistry to meet these challenges. In addition, international organisations are developing new funding and licensing pathways for vaccines aimed at pathogens with epidemic potential that emerge from tropical areas.",

keywords = "CMV, Dengue, HIV, Host immunity, Influenza, Pertussis, RSV, Rotavirus, Structural biology, Vaccinology",

author = "Rodrigues, \{Charlene M.C.\} and Pinto, \{Marta V.\} and Manish Sadarangani and Plotkin, \{Stanley A.\}",

note = "Publisher Copyright: {\textcopyright} 2017 The British Infection Association",

year = "2017",

month = jun,

doi = "10.1016/S0163-4453(17)30184-6",

language = "English",

volume = "74",

pages = "S2--S9",

journal = "Journal of Infection",